Press releases

Release
31.10.2019

VALBIOTIS announces the success of its capital increase with maintenance of the DPS for an amount of 7.2 million euros (in French)

Download
Release
10.10.2019

VALBIOTIS launches a share capital increase with Shareholders’ Preferential Subscription Rights (in French)

Download
Release
16.09.2019

VALBIOTIS presents positive results from a study on TOTUM-63, active substance of VALEDIA®, at EASD 2019

Download
Release
02.09.2019

Additional positive results from the Phase IIA clinical study on VALEDIA® in lipid metabolism and arterial hypertension

Download
Release
30.08.2019

2019 half-year report and update on key achievements (in French)

Download
Release
01.08.2019

Provision of the Registration Document (R 19-030) and Statement of cash position as of June 30, 2019 (in French)

Download
Release
26.07.2019

Half year report of the liquidity contract – July 2019 (in French)

Download
Release
03.07.2019

VALBIOTIS announces positive results from the Phase IIA clinical study of VALEDIA®, now the first product proven effective in people with prediabetes

Download
Release
24.06.2019

VALBIOTIS participates in the first HealthTech Investor Days, organized by France Biotech

Download